101 related articles for article (PubMed ID: 27590514)
1. Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide.
Wick W; Roth P; Hartmann C; Hau P; Nakamura M; Stockhammer F; Sabel MC; Wick A; Koeppen S; Ketter R; Vajkoczy P; Eyupoglu I; Kalff R; Pietsch T; Happold C; Galldiks N; Schmidt-Graf F; Bamberg M; Reifenberger G; Platten M; von Deimling A; Meisner C; Wiestler B; Weller M;
Neuro Oncol; 2016 Nov; 18(11):1529-1537. PubMed ID: 27370396
[TBL] [Abstract][Full Text] [Related]
2. Secondary hematological malignancies associated with temozolomide in patients with glioma.
Momota H; Narita Y; Miyakita Y; Shibui S
Neuro Oncol; 2013 Oct; 15(10):1445-50. PubMed ID: 23519741
[TBL] [Abstract][Full Text] [Related]
3. Phase 2 study of temozolomide-based chemoradiation therapy for high-risk low-grade gliomas: preliminary results of Radiation Therapy Oncology Group 0424.
Fisher BJ; Hu C; Macdonald DR; Lesser GJ; Coons SW; Brachman DG; Ryu S; Werner-Wasik M; Bahary JP; Liu J; Chakravarti A; Mehta M
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):497-504. PubMed ID: 25680596
[TBL] [Abstract][Full Text] [Related]
4. Post-radiotherapy apparent diffusion coefficient (ADC) in children and young adults with high-grade gliomas and diffuse intrinsic pontine gliomas.
Carceller F; Jerome NP; Fowkes LA; Khabra K; Mackinnon A; Bautista F; Marshall LV; Vaidya S; Mandeville H; Morgan V; Leach MO; Koh DM
Pediatr Hematol Oncol; 2019 Mar; 36(2):103-112. PubMed ID: 30978130
[No Abstract] [Full Text] [Related]
5. Intratumoral temozolomide synergizes with immunotherapy in a T cell-dependent fashion.
Fritzell S; Sandén E; Eberstål S; Visse E; Darabi A; Siesjö P
Cancer Immunol Immunother; 2013 Sep; 62(9):1463-74. PubMed ID: 23775421
[TBL] [Abstract][Full Text] [Related]
6. Study of radiochemotherapy decision-making for young high-risk low-grade glioma patients using a macroscopic and microscopic combined radiomics model.
Wu G; Shi Z; Li Z; Xie X; Tang Q; Zhu J; Yang Z; Wang Y; Wu J; Yu J
Eur Radiol; 2024 May; 34(5):2861-2872. PubMed ID: 37889272
[TBL] [Abstract][Full Text] [Related]
7. Does the interval from tumour surgery to radiotherapy influence survival in paediatric high grade glioma?
Azizi AA; Paur S; Kaider A; Dieckmann K; Peyrl A; Chocholous M; Czech T; Slavc I
Strahlenther Onkol; 2018 Jun; 194(6):552-559. PubMed ID: 29349602
[TBL] [Abstract][Full Text] [Related]
8. The role of adjuvant chemotherapy in patients with H3K27 altered diffuse midline gliomas: a multicentric retrospective study.
Di Nunno V; Lombardi G; Simonelli M; Minniti G; Mastronuzzi A; Di Ruscio V; Corrà M; Padovan M; Maccari M; Caccese M; Simonetti G; Berlendis A; Farinotti M; Pollo B; Antonelli M; Di Muzio A; Dipasquale A; Asioli S; De Biase D; Tosoni A; Silvani A; Franceschi E
J Neurooncol; 2024 Mar; 167(1):145-154. PubMed ID: 38457090
[TBL] [Abstract][Full Text] [Related]
9. A pilot study: 131I-antitenascin monoclonal antibody 81c6 to deliver a 44-Gy resection cavity boost.
Reardon DA; Zalutsky MR; Akabani G; Coleman RE; Friedman AH; Herndon JE; McLendon RE; Pegram CN; Quinn JA; Rich JN; Vredenburgh JJ; Desjardins A; Guruangan S; Boulton S; Raynor RH; Dowell JM; Wong TZ; Zhao XG; Friedman HS; Bigner DD
Neuro Oncol; 2008 Apr; 10(2):182-9. PubMed ID: 18287339
[TBL] [Abstract][Full Text] [Related]
10. Blood glutamate scavengers prolong the survival of rats and mice with brain-implanted gliomas.
Ruban A; Berkutzki T; Cooper I; Mohar B; Teichberg VI
Invest New Drugs; 2012 Dec; 30(6):2226-35. PubMed ID: 22392507
[TBL] [Abstract][Full Text] [Related]
11. Neuropsychological functioning during chemotherapy with temozolomide in high-grade glioma patients: a retrospective single centre study.
Abete-Fornara G; Bintintan Socaciu P; Fanizzi C; Fiore G; Locatelli M; Caroli M
J Neurooncol; 2023 Dec; 165(3):561-568. PubMed ID: 38108984
[TBL] [Abstract][Full Text] [Related]
12. Outcome of patients with malignant glioma and synchronous or metachronous non-central nervous system primary neoplasms.
Hamza MA; Kamiya-Matsuoka C; Liu D; Yuan Y; Puduvalli VK
J Neurooncol; 2016 Feb; 126(3):527-33. PubMed ID: 26566652
[TBL] [Abstract][Full Text] [Related]
13. Effect of Temozolomide Combined with Intensity Modulated Radiation Therapy on Serum Factor, Immune Function and Clinical Efficacy in Postoperative Glioma Patients.
Yuan J; Liu J; Fan R; Liu Z
Radiat Res; 2023 Sep; 200(3):289-295. PubMed ID: 37797165
[TBL] [Abstract][Full Text] [Related]
14. The angiogenic switch leads to a metabolic shift in human glioblastoma.
Talasila KM; Røsland GV; Hagland HR; Eskilsson E; Flønes IH; Fritah S; Azuaje F; Atai N; Harter PN; Mittelbronn M; Andersen M; Joseph JV; Hossain JA; Vallar L; Noorden CJ; Niclou SP; Thorsen F; Tronstad KJ; Tzoulis C; Bjerkvig R; Miletic H
Neuro Oncol; 2017 Mar; 19(3):383-393. PubMed ID: 27591677
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapy with or without temozolomide in elderly patients aged ≥ 70 years with glioblastoma.
Metcalfe E; Karaoglanoglu O; Akyazici E
Contemp Oncol (Pozn); 2016; 20(3):251-5. PubMed ID: 27647990
[TBL] [Abstract][Full Text] [Related]
16. Combination of lentivirus-mediated silencing of PPM1D and temozolomide chemotherapy eradicates malignant glioma through cell apoptosis and cell cycle arrest.
Wang P; Ye JA; Hou CX; Zhou D; Zhan SQ
Oncol Rep; 2016 Nov; 36(5):2544-2552. PubMed ID: 27633132
[TBL] [Abstract][Full Text] [Related]
17. Gene Expression and Methylation Analyses Suggest DCTD as a Prognostic Factor in Malignant Glioma.
Hu H; Wang Z; Li M; Zeng F; Wang K; Huang R; Wang H; Yang F; Liang T; Huang H; Jiang T
Sci Rep; 2017 Sep; 7(1):11568. PubMed ID: 28912488
[TBL] [Abstract][Full Text] [Related]
18. Radiation combined with temozolomide contraindicated for young adults diagnosed with anaplastic glioma.
Yang P; Zhang C; Cai J; You G; Wang Y; Qiu X; Li S; Wu C; Yao K; Li W; Peng X; Zhang W; Jiang T
Oncotarget; 2016 Nov; 7(48):80091-80100. PubMed ID: 27590514
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE study.
Perry JR; Bélanger K; Mason WP; Fulton D; Kavan P; Easaw J; Shields C; Kirby S; Macdonald DR; Eisenstat DD; Thiessen B; Forsyth P; Pouliot JF
J Clin Oncol; 2010 Apr; 28(12):2051-7. PubMed ID: 20308655
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]